BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36961416)

  • 1. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
    Yang X; Mei C; Nie H; Zhou J; Ou C; He X
    Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma.
    Gui Y; Liu X; Wang C; Yang P
    World J Surg Oncol; 2021 Apr; 19(1):111. PubMed ID: 33845847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
    Zhao T; Li X; Li M; Jamil M; Zhang J
    Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 6. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.
    Lin J; Chen L; Wu D; Lin J; Liu B; Guo C
    Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
    Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
    Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
    Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
    Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC).
    Zhang Y; Lai H; Tang B
    Dis Markers; 2021; 2021():4570235. PubMed ID: 34539936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma.
    Peng LS; Duan SL; Li RQ; Bai ZY; Ou CL; Wang JP
    PeerJ; 2023; 11():e15154. PubMed ID: 37096064
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.
    Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL
    Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.